Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
Wei Huang, Chenze Li, Zhiquan Wang, et al.
Science China Life Sciences (2020) Vol. 63, Iss. 11, pp. 1678-1687
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19
Fen Zhang, Yating Wan, Tao Zuo, et al.
Gastroenterology (2021) Vol. 162, Iss. 2, pp. 548-561.e4
Open Access | Times Cited: 199
Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection
Xingzhong Hu, Dong Chen, Lianpeng Wu, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 105-110
Open Access | Times Cited: 173
Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19
Gulam Rabbani, Saeyoung Nate Ahn
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 948-955
Open Access | Times Cited: 115
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Bo Yu, Chenze Li, Yang Sun, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 65-77.e2
Open Access | Times Cited: 135
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19
Guohui Xue, Xing Gan, Zhìqiáng Wú, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107065-107065
Open Access | Times Cited: 105
Altered high-density lipoprotein composition and functions during severe COVID-19
Floran Bègue, Sébastien Tanaka, Zarouki Mouktadi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 91
Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
Angelo Zinellu, Panagiotis Paliogiannis, Alessandro G. Fois, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 67
Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis
Panagiotis Paliogiannis, Arduino A. Mangoni, Michela Cangemi, et al.
Clinical and Experimental Medicine (2021) Vol. 21, Iss. 3, pp. 343-354
Open Access | Times Cited: 66
Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity
Kyung‐Hyun Cho, Jae-Ryong Kim, In‐Chul Lee, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 209-209
Open Access | Times Cited: 63
Approaches to Nutritional Screening in Patients with Coronavirus Disease 2019 (COVID-19)
Amira Mohammed Ali, Hiroshi Kunugi
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 5, pp. 2772-2772
Open Access | Times Cited: 57
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes‐Alvarez, Nathaly Limon‐de la Rosa, Moisés Salgado-de la Mora, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 54
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 45
Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients
İnanç Karakoyun, Ayfer Çolak, Melda Türken, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107285-107285
Open Access | Times Cited: 67
Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
Ligong Lu, Hui Zhang, Meixiao Zhan, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 63
Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis
Szabolcs Kiss, Noémi Gede, Péter Hegyi, et al.
Medical Microbiology and Immunology (2020) Vol. 210, Iss. 1, pp. 33-47
Open Access | Times Cited: 62
Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study
María C. Viana‐Llamas, Ramón Arroyo‐Espliguero, José Alberto Silva, et al.
Medicina Clínica (2021) Vol. 156, Iss. 9, pp. 428-436
Open Access | Times Cited: 56
Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China
Yuan Xu, Huan Yang, Jing Wang, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2785-2797
Open Access | Times Cited: 45
Development of novel spectroscopic and machine learning methods for the measurement of periodic changes in COVID-19 antibody level
Zozan Güleken, Yeşim Tok, Paweł Jakubczyk, et al.
Measurement (2022) Vol. 196, pp. 111258-111258
Open Access | Times Cited: 30
The bidirectional interaction of COVID-19 infections and lipoproteins
Kenneth R. Feingold
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101751-101751
Open Access | Times Cited: 20
COVID-19 and liver injury: An ongoing challenge
Ioanna Papagiouvanni, Serafeim‐Chrysovalantis Kotoulas, Athanasia Pataka, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 257-271
Open Access | Times Cited: 19
The bidirectional link between HDL and COVID-19 infections
Kenneth R. Feingold
Journal of Lipid Research (2021) Vol. 62, pp. 100067-100067
Open Access | Times Cited: 38
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio
Yi Li, Haitao Li, Chao Song, et al.
Disease Markers (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 36
Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action
Amira Mohammed Ali, Hiroshi Kunugi
Diagnostic Pathology (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 34
Understanding protection from SARS-CoV-2 using metabolomics
E. Barberis, Elia Amede, Matteo Tavecchia, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications
Alessandra Stasi, Rossana Franzin, Marco Fiorentino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5980-5980
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top